91 related articles for article (PubMed ID: 30111974)
1. Are clinical trial eligibility criteria an accurate reflection of a real-world population of advanced non-small-cell lung cancer patients?
Al-Baimani K; Jonker H; Zhang T; Goss GD; Laurie SA; Nicholas G; Wheatley-Price P
Curr Oncol; 2018 Aug; 25(4):e291-e297. PubMed ID: 30111974
[TBL] [Abstract][Full Text] [Related]
2. The bottleneck effect in lung cancer clinical trials.
Gonzalez LE; Sutton SK; Pratt C; Gilbertson M; Antonia S; Quinn GP
J Cancer Educ; 2013 Sep; 28(3):488-93. PubMed ID: 23733149
[TBL] [Abstract][Full Text] [Related]
3. Broadening Eligibility Criteria and Diversity among Patients for Cancer Clinical Trials.
Kaur M; Frahm F; Lu Y; Ascha MS; Guadamuz JS; Dotan E; Gottesman AS; Leybovich BC; Sondhi A; Zhao Y; Meropol NJ; Royce TJ
NEJM Evid; 2024 Apr; 3(4):EVIDoa2300236. PubMed ID: 38771994
[TBL] [Abstract][Full Text] [Related]
4. Checkpoint Inhibitor Monotherapy in Potentially Trial-Eligible or Trial-Ineligible Patients With Metastatic NSCLC in the German Prospective CRISP Registry Real-World Cohort (AIO-TRK-0315).
Griesinger F; Sebastian M; Brueckl WM; Hummel HD; Jaeschke B; Kern J; Wesseler C; Jänicke M; Fleitz A; Zacharias S; Hipper A; Groth A; Weichert W; Dörfel S; Petersen V; Schröder J; Wilke J; Eberhardt WEE; Thomas M;
JTO Clin Res Rep; 2024 Apr; 5(4):100626. PubMed ID: 38586301
[TBL] [Abstract][Full Text] [Related]
5. Thoracic Oncology Clinical Trial Eligibility Criteria and Requirements Continue to Increase in Number and Complexity.
Garcia S; Bisen A; Yan J; Xie XJ; Ramalingam S; Schiller JH; Johnson DH; Gerber DE
J Thorac Oncol; 2017 Oct; 12(10):1489-1495. PubMed ID: 28802905
[TBL] [Abstract][Full Text] [Related]
6. Quantitative evaluation of the impact of relaxing eligibility criteria on the risk-benefit profile of drugs for lung cancer based on real-world data.
Huang H; Jia S; Wang X; Miao H; Fang H; He H; Wu D; Tang Y; Li N
Thorac Cancer; 2024 May; 15(14):1187-1194. PubMed ID: 38576119
[TBL] [Abstract][Full Text] [Related]
7. Lung Cancer Presents at a Younger Age and Is Less Likely to be Curable in People Living with HIV.
Bhikoo R; Allwood BW; Irusen EM; Koegelenberg CFN
Respiration; 2024; 103(1):47-50. PubMed ID: 37879317
[TBL] [Abstract][Full Text] [Related]
8. Examining Exclusion Criteria in Advanced Prostate Cancer Clinical Trials: An Assessment of recommendations From the American Society Of Clinical Oncology and Friends of Cancer Research.
Ebrahimi H; Castro DV; Feng MI; Prajapati SR; Lee KO; Chan EH; Paul T; Sehgal I; Patel J; Li X; Zengin ZB; Meza L; Mercier BD; Hsu J; Govindarajan A; Chawla N; Dizman N; Bergerot CD; Rock A; Liu S; Tripathi A; Dorff T; Pal SK; Chehrazi-Raffle A
Clin Genitourin Cancer; 2023 Dec; 21(6):e467-e473. PubMed ID: 37301665
[TBL] [Abstract][Full Text] [Related]
9. Racial Disparities in Endometrial Cancer Clinical Trial Representation: Exploring the Role of Eligibility Criteria.
Wolf JL; Hamilton A; An A; Leonard JP; Kanis MJ
Am J Clin Oncol; 2024 May; ():. PubMed ID: 38700907
[TBL] [Abstract][Full Text] [Related]
10. Modernizing Clinical Trial Eligibility Criteria: Recommendations of the ASCO-Friends of Cancer Research Performance Status Work Group.
Magnuson A; Bruinooge SS; Singh H; Wilner KD; Jalal S; Lichtman SM; Kluetz PG; Lyman GH; Klepin HD; Fleury ME; Hirsch B; Melemed A; Arnaldez FI; Basu Roy U; Schenkel C; Sherwood S; Garrett-Mayer E
Clin Cancer Res; 2021 May; 27(9):2424-2429. PubMed ID: 33563633
[TBL] [Abstract][Full Text] [Related]
11. OWL model of clinical trial eligibility criteria compatible with partially-known information.
Dameron O; Besana P; Zekri O; Bourdé A; Burgun A; Cuggia M
J Biomed Semantics; 2013 Sep; 4(1):17. PubMed ID: 24034867
[TBL] [Abstract][Full Text] [Related]
12. Effect of Eligibility Criteria on Patients' Survival and Serious Adverse Events in Colorectal Cancer Drug Trials.
Wang C; Chen A; He X; Balian P; George TJ; Wang F; Bian J; Guo Y
medRxiv; 2024 Apr; ():. PubMed ID: 38633798
[TBL] [Abstract][Full Text] [Related]
13. Clinical trials in advanced stage lung cancer: a survey of patients' opinion about their treatment.
Zaric B; Perin B; Ilic A; Kopitovic I; Matijasevic J; Andrijevic L; Secen N; Stanic J; Bijelovic M; Kosjerina Z; Antonic M
Multidiscip Respir Med; 2011 Feb; 6(1):20-7. PubMed ID: 22958587
[TBL] [Abstract][Full Text] [Related]
14. How Have Cancer Clinical Trial Eligibility Criteria Evolved Over Time?
Yaman A; Chakrabarti S; Sen A; Weng C
AMIA Jt Summits Transl Sci Proc; 2016; 2016():269-78. PubMed ID: 27570681
[TBL] [Abstract][Full Text] [Related]
15. Correction to: Eligibility for Cardiovascular Risk Reduction Therapy in the U.S. Based on SELECT Trial Criteria: Insights from the National Health and Nutrition Examination Survey.
Circ Cardiovasc Qual Outcomes; 2024 Jan; 17(1):e000126. PubMed ID: 38226475
[No Abstract] [Full Text] [Related]
16. Eligibility criteria: too big, too small or just right?
Atallah E
Haematologica; 2024 Apr; 109(4):1021. PubMed ID: 37822257
[No Abstract] [Full Text] [Related]
17. Use of Healthcare Claims Data to Generate Real-World Evidence on Patients With Drug-Resistant Epilepsy: Practical Considerations for Research.
Stamas N; Vincent T; Evans K; Li Q; Danielson V; Lassagne R; Berger A
J Health Econ Outcomes Res; 2024; 11(1):57-66. PubMed ID: 38425708
[No Abstract] [Full Text] [Related]
18. Choosing the optimal immunotherapeutic strategies for non-small cell lung cancer based on clinical factors.
Nakagawa N; Kawakami M
Front Oncol; 2022; 12():952393. PubMed ID: 36033471
[TBL] [Abstract][Full Text] [Related]
19. Illness perception profiles and psychological and physical symptoms in newly diagnosed advanced non-small cell lung cancer.
Valentine TR; Presley CJ; Carbone DP; Shields PG; Andersen BL
Health Psychol; 2022 Jun; 41(6):379-388. PubMed ID: 35604701
[TBL] [Abstract][Full Text] [Related]
20. Barriers to patient enrolment in phase III cancer clinical trials: interviews with clinicians and pharmaceutical industry representatives.
Dane A; Ashraf S; Timmis J; Bos M; Uyl-de Groot C; van der Kuy PHM
BMJ Open; 2022 Feb; 12(2):e055165. PubMed ID: 35177455
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
